CheckMyRecalls

Sagent Pharmaceuticals recalls Busulfan Injection

Published
27 May 2026
Units affected
Lot 656412: 6,200 vials. Lot 659646: 3,328 vials.
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Busulfan Injection, 60 mg per 10 mL (6 mg per mL), 8x10 mL Single-Dose Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, Made in Canada, NDC 25021-241-10.

Brand / company
Sagent Pharmaceuticals
Codes / lots
Lot #: 656412, Exp. Date 08/31/2026; 659646, Exp. Date 03/31/2027.
Distribution
Nationwide within the United States
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 27 May 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.